O CARE PHARMA: what changed
O CARE PHARMA
Largest movements
- Receivables within one year -€35,955
down €35,955 (-68.3%), from €52,619 to €16,664
of which Trade receivables: -€33,175
- Cash -€12,877
down €12,877 (-27.2%), from €47,354 to €34,477
mainly Net result for the year (-€47,460) and Debts after one year (-€30,495)
- Stocks and contracts +€12,225
up €12,225 (+16.6%), from €73,568 to €85,793
- Intangible fixed assets -€4,883
down €4,883 (-32.7%), from €14,927 to €10,044
- Profit (loss) carried forward -€47,460
down €47,460 (-80.5%), from -€58,946 to -€106,406
- Debts after one year -€30,495
down €30,495 (-23.2%), from €131,518 to €101,023
- Current portion of long-term debt +€15,511
up €15,511 (+104%), from €14,984 to €30,495
- Tax, wage and social debts +€11,704
up €11,704 (+248%), from €4,728 to €16,432
of which Remuneration and social security: +€9,329
- Trade debts +€9,009
up €9,009 (+50.4%), from €17,879 to €26,888
- Gross operating margin -€22,962
down €22,962 (-32.2%), from €71,416 to €48,454
- Staff costs +€20,290
up €20,290 (+32.3%), from €62,730 to €83,020
- Depreciation -€1,554
down €1,554 (-24.1%), from €6,436 to €4,883
Change in the result, 2024 to 2025
For each income-statement line you see the change as its effect on the result. Higher costs lower the result, higher income raises it.
Derived cash bridge
The bridge is derived from the 2024 and 2025 balance sheets and the 2025 result. There is no filed cash-flow statement. You see where the money came from and where it went.
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €189,838 | €147,746 | -€42,092 | -22.2% |
| Fixed assets | 21/28 | €15,677 | €10,794 | -€4,883 | -31.1% |
| Intangible fixed assets | 21 | €14,927 | €10,044 | -€4,883 | -32.7% |
| Financial fixed assets | 28 | €750 | €750 | = | 0.0% |
| Current assets | 29/58 | €174,161 | €136,953 | -€37,209 | -21.4% |
| Stocks and contracts in progress | 3 | €73,568 | €85,793 | +€12,225 | +16.6% |
| Stocks | 30/36 | €73,568 | €85,793 | +€12,225 | +16.6% |
| Amounts receivable within one year | 40/41 | €52,619 | €16,664 | -€35,955 | -68.3% |
| Trade receivables | 40 | €48,789 | €15,614 | -€33,175 | -68.0% |
| Other amounts receivable | 41 | €3,830 | €1,050 | -€2,780 | -72.6% |
| Cash at bank and in hand | 54/58 | €47,354 | €34,477 | -€12,877 | -27.2% |
| Deferred charges and accrued income | 490/1 | €620 | €18 | -€602 | -97.0% |
| Total equity and liabilities | 10/49 | €189,838 | €147,746 | -€42,092 | -22.2% |
| Equity | 10/15 | -€38,946 | -€86,406 | -€47,460 | -122% |
| Contributions | 10/11 | €20,000 | €20,000 | = | 0.0% |
| Profit (loss) carried forward | 14 | -€58,946 | -€106,406 | -€47,460 | -80.5% |
| Amounts payable | 17/49 | €228,785 | €234,153 | +€5,368 | +2.3% |
| Amounts payable after more than one year | 17 | €131,518 | €101,023 | -€30,495 | -23.2% |
| Financial debts | 170/4 | €131,518 | €101,023 | -€30,495 | -23.2% |
| Amounts payable within one year | 42/48 | €96,824 | €133,130 | +€36,306 | +37.5% |
| Current portion of amounts payable after more than one year | 42 | €14,984 | €30,495 | +€15,511 | +104% |
| Trade debts | 44 | €17,879 | €26,888 | +€9,009 | +50.4% |
| Suppliers | 440/4 | €17,879 | €26,888 | +€9,009 | +50.4% |
| Taxes, remuneration and social security | 45 | €4,728 | €16,432 | +€11,704 | +248% |
| Taxes | 450/3 | €425 | €2,800 | +€2,375 | +559% |
| Remuneration and social security | 454/9 | €4,303 | €13,632 | +€9,329 | +217% |
| Other amounts payable | 47/48 | €59,233 | €59,315 | +€82 | +0.1% |
| Accrued charges and deferred income | 492/3 | €443 | €0 | -€443 | -100% |
| Remuneration, social security and pensions | 62 | €62,730 | €83,020 | +€20,290 | +32.3% |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets | 630 | €6,436 | €4,883 | -€1,554 | -24.1% |
| Other operating charges | 640/8 | €513 | €527 | +€14 | +2.8% |
| Gross operating margin | 9900 | €71,416 | €48,454 | -€22,962 | -32.2% |
| Operating profit (loss) | 9901 | €1,736 | -€39,977 | -€41,713 | |
| Financial income | 75/76B | €0 | €0 | -€0 | -100% |
| Recurring financial income | 75 | €0 | €0 | -€0 | -100% |
| Financial charges | 65/66B | €7,103 | €7,392 | +€289 | +4.1% |
| Recurring financial charges | 65 | €7,103 | €7,392 | +€289 | +4.1% |
| Profit (loss) for the period before taxes | 9903 | -€5,367 | -€47,369 | -€42,002 | -783% |
| Income taxes | 67/77 | €51 | €91 | +€40 | +77.8% |
| Profit (loss) for the period | 9904 | -€5,418 | -€47,460 | -€42,042 | -776% |
| Profit (loss) for the period to be appropriated | 9905 | -€5,418 | -€47,460 | -€42,042 | -776% |
Next steps
Calculation and sources
Source: filed annual accounts (NBB), financial years ended 31 December 2024 and 31 December 2025. Green is a favourable move for that line, red an unfavourable one. Prepared on 3 November 2026 via checked.be.